This company has been marked as potentially delisted and may not be actively trading. NASDAQ:EXAC Exactech (EXAC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Exactech Stock (NASDAQ:EXAC) 30 days 90 days 365 days Advanced Chart Get Exactech alerts:Sign Up Key Stats Today's Range$49.25▼$49.3050-Day Range N/A52-Week Range$23.75▼$50.95Volume255,640 shsAverage Volume182,742 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewExactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.Read More… Receive EXAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exactech and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAC Stock News HeadlinesVIDEO: Wind, hail reported across Gainesville and Alachua CountyApril 11, 2025 | msn.comBoots on the Ground: Reliving the Gainesville National Championship ExperienceApril 10, 2025 | msn.comReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.April 27, 2025 | Premier Gold Co (Ad)1,000 Miles from San Antonio, Gator Nation Filling Streets to Watch ChampionshipApril 8, 2025 | msn.comExactech Unveils Next Generation of Predict+®, the First Machine Learning Tool for Predictive Outcomes in Shoulder Replacement SurgeryApril 7, 2025 | finance.yahoo.comUF to Host Championship Watch PartyApril 6, 2025 | msn.comSon of NBA all-time great joins Sacramento State basketball under Mike BibbyApril 2, 2025 | msn.comUSPTO issues patent for Exactech’s soft tissue balancing technologyMarch 20, 2025 | finance.yahoo.comSee More Headlines EXAC Stock Analysis - Frequently Asked Questions How were Exactech's earnings last quarter? Exactech Inc (NASDAQ:EXAC) posted its earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.03. The medical equipment provider had revenue of $61.40 million for the quarter, compared to analyst estimates of $61.78 million. What other stocks do shareholders of Exactech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Exactech investors own include Immersion (IMMR), Verizon Communications (VZ), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ), Meta Platforms (META), Riot Platforms (RIOT) and Allergan (AGN). Company Calendar Last Earnings10/30/2017Today4/27/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:EXAC CIK913165 Webwww.exac.com Phone+1-352-3771140FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:EXAC) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exactech Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Exactech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.